| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Precigen, Inc. (PGEN) has 13 insiders with recent SEC Form 4 filings, including 137 buys and 13 sells. PGEN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 3.77M | $20.28M | -119,250 | |
| Other | 755.5K | $4.06M | -29,131 | |
| Dir | 613.6K | $3.30M | - | |
| CFO | 554.5K | $2.98M | -41,884 | |
| COO | 497.8K | $2.68M | -42,703 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 30, 2019 | Kirk Randal J | Chief Executive Officer | Buy | 495,271 | $4.75 | $2,351,703.40 | +1.1% | |
| May 24, 2019 | Kirk Randal J | Chief Executive Officer | Buy | 410,050 | $4.69 | $1,921,203.32 | +0.6% | |
| May 24, 2019 | Kirk Randal J | Chief Executive Officer | Buy | 273,367 | $4.69 | $1,280,803.80 | +4.3% | |
| May 21, 2019 | Kirk Randal J | Chief Executive Officer | Buy | 633,631 | $4.65 | $2,949,096.02 | +1.0% | |
| May 21, 2019 | Kirk Randal J | Chief Executive Officer | Buy | 422,423 | $4.65 | $1,966,074.82 | +8.0% | |
| May 15, 2019 | Kirk Randal J | Chief Executive Officer | Buy | 838,482 | $4.40 | $3,688,025.50 | +26.1% | |
| May 15, 2019 | Kirk Randal J | Chief Executive Officer | Buy | 1,257,727 | $4.40 | $5,532,056.05 | +2.0% | |
| Apr 3, 2019 | Kirk Randal J | 10% Owner | Sell | 150,565 | $0.66 | $98,837.27 | -14.5% | |
| Mar 5, 2019 | Reed Thomas D. | Chief Science Officer | Sell | 227,800 | $4.19 | $954,408.00 | -49.1% | |
| Jan 15, 2019 | Kirk Randal J | 10% Owner | Sell | 998,204 | $0.16 | $158,771.67 | -13.9% |